A Phase 2 Study of Oral Enzastaurin HCl in Patients with Metastatic Colorectal Cancer

Update Il y a 4 ans
Reference: EUCTR2004-005068-26

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Main objective :To estimate the 6-month (24 weeks) progression-free survival for patients with metastatic CRC who are treated with enzastaurin.


Inclusion criteria

  • Metastatic colorectal cancer